NDUFB2P1

Across TCGA pan-cancer cohorts, NDUFB2P1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated NDUFB2P1 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher NDUFB2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NDUFB2P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

LUSC, KIRP, and UCEC are the cancer types where NDUFB2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.214	0.668	.005	90	view →
KIRP	OS	Tertile	II,III,IV	0.111	0.769	<.001	54	view →
UCEC	OS	Tertile	II,III,IV	0.536	0.856	.002	36	view →
LGG	OS	Tertile	All	0.777	0.902	.006	30	view →
LIHC	DFS	Tertile	All	0.126	0.530	.016	27	view →
READ	DFS	Tertile	III,IV	0.082	0.746	<.001	18	view →
LUAD	DFS	Tertile	II,III,IV	0.503	0.692	.025	18	view →
THCA	DFS	Tertile	All	0.486	0.841	.005	18	view →
KIRC	DFS	Tertile	IV	0.327	0.524	.031	12	view →
SARC	OS	Tertile	All	0.423	0.831	.019	9	view →
HNSC	OS	Tertile	All	0.957	0.744	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

NDUFB2P1–LUSC (DFS)

Open the LUSC breakdown →